3-184372478-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000460.4(THPO):​c.*35G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.549 in 1,612,896 control chromosomes in the GnomAD database, including 252,407 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.64 ( 33975 hom., cov: 32)
Exomes 𝑓: 0.54 ( 218432 hom. )

Consequence

THPO
NM_000460.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.410

Publications

47 publications found
Variant links:
Genes affected
THPO (HGNC:11795): (thrombopoietin) Megakaryocytopoiesis is the cellular development process that leads to platelet production. The main functional protein encoded by this gene is a humoral growth factor that is necessary for megakaryocyte proliferation and maturation, as well as for thrombopoiesis. This protein is the ligand for MLP/C_MPL, the product of myeloproliferative leukemia virus oncogene. Mutations in this gene are the cause of thrombocythemia 1. Alternative promoter usage and differential splicing result in multiple transcript variants differing in the 5' UTR and/or coding region. Multiple AUG codons upstream of the main open reading frame (ORF) have been identified, and these upstream AUGs inhibit translation of the main ORF at different extent. [provided by RefSeq, Feb 2014]
THPO Gene-Disease associations (from GenCC):
  • thrombocythemia 1
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: ClinGen, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • congenital amegakaryocytic thrombocytopenia
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • familial thrombocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary isolated aplastic anemia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary thrombocytosis with transverse limb defect
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital amegakaryocytic thrombocytopenia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 3-184372478-C-T is Benign according to our data. Variant chr3-184372478-C-T is described in ClinVar as Benign. ClinVar VariationId is 344369.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.91 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
THPONM_000460.4 linkc.*35G>A 3_prime_UTR_variant Exon 6 of 6 ENST00000647395.1 NP_000451.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
THPOENST00000647395.1 linkc.*35G>A 3_prime_UTR_variant Exon 6 of 6 NM_000460.4 ENSP00000494504.1 P40225-1

Frequencies

GnomAD3 genomes
AF:
0.641
AC:
97415
AN:
151974
Hom.:
33917
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.917
Gnomad AMI
AF:
0.549
Gnomad AMR
AF:
0.652
Gnomad ASJ
AF:
0.686
Gnomad EAS
AF:
0.439
Gnomad SAS
AF:
0.485
Gnomad FIN
AF:
0.364
Gnomad MID
AF:
0.725
Gnomad NFE
AF:
0.537
Gnomad OTH
AF:
0.680
GnomAD2 exomes
AF:
0.559
AC:
140412
AN:
251394
AF XY:
0.547
show subpopulations
Gnomad AFR exome
AF:
0.924
Gnomad AMR exome
AF:
0.641
Gnomad ASJ exome
AF:
0.692
Gnomad EAS exome
AF:
0.435
Gnomad FIN exome
AF:
0.375
Gnomad NFE exome
AF:
0.544
Gnomad OTH exome
AF:
0.586
GnomAD4 exome
AF:
0.540
AC:
788670
AN:
1460806
Hom.:
218432
Cov.:
39
AF XY:
0.537
AC XY:
389956
AN XY:
726810
show subpopulations
African (AFR)
AF:
0.931
AC:
31150
AN:
33472
American (AMR)
AF:
0.645
AC:
28825
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.690
AC:
18034
AN:
26134
East Asian (EAS)
AF:
0.447
AC:
17736
AN:
39694
South Asian (SAS)
AF:
0.479
AC:
41281
AN:
86198
European-Finnish (FIN)
AF:
0.381
AC:
20328
AN:
53408
Middle Eastern (MID)
AF:
0.713
AC:
4022
AN:
5638
European-Non Finnish (NFE)
AF:
0.533
AC:
592080
AN:
1111192
Other (OTH)
AF:
0.584
AC:
35214
AN:
60348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
20649
41298
61947
82596
103245
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16902
33804
50706
67608
84510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.641
AC:
97526
AN:
152090
Hom.:
33975
Cov.:
32
AF XY:
0.629
AC XY:
46729
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.918
AC:
38113
AN:
41534
American (AMR)
AF:
0.652
AC:
9954
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.686
AC:
2380
AN:
3470
East Asian (EAS)
AF:
0.439
AC:
2266
AN:
5162
South Asian (SAS)
AF:
0.485
AC:
2336
AN:
4816
European-Finnish (FIN)
AF:
0.364
AC:
3845
AN:
10558
Middle Eastern (MID)
AF:
0.731
AC:
215
AN:
294
European-Non Finnish (NFE)
AF:
0.537
AC:
36496
AN:
67966
Other (OTH)
AF:
0.675
AC:
1421
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1536
3073
4609
6146
7682
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
740
1480
2220
2960
3700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.578
Hom.:
81865
Bravo
AF:
0.678
Asia WGS
AF:
0.527
AC:
1831
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Thrombocythemia 1 Benign:2
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
Oct 16, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 11257273) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
3.2
DANN
Benign
0.49
PhyloP100
-0.41
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6141; hg19: chr3-184090266; COSMIC: COSV52615748; COSMIC: COSV52615748; API